Special on B2B   A Commercial Feature
 
Business Standard
A COMMERCIAL FEATURE
Read more on:   
|
|
|
|
|
|
|

Japan's Tosoh acquires in-vitro diagnostics firm Lilac Medicare

With this move, Tosoh aims to increase its share in the growing Indian market by using its own immunological and diabetes diagnostic analysers

With this move, Tosoh aims to increase its share in the growing Indian market by using its own immunological and diabetes diagnostic analysers Japanese firm Corporation, as a part of its strategy to expand and strengthen its bioscience operations, has acquired the Mumbai-based company Pvt Ltd for an undisclosed amount. As a result of this transaction, Lilac Medicare, which was established in 1997, becomes a part of the Group.
 
“By utilising the network Lilac has built, will make further efforts to increase its share in the growing Indian market by using its own and as stepping stones towards expanding its bioscience business and establishing a firm position in India,” said in a press release.
 
Lilac Medicare, which has 135 employees, manufactures and supplies clinical diagnostic equipment and reagents.
 
The $7.5-billion Tosoh, which is one of the largest chlor-alkali manufacturers in Asia, supplies the plastic resins and an array of the basic chemicals that support modern life. Tosoh’s petrochemical operations supply ethylene, polyethylene, and functional polymers, while its advanced materials business serves the global semiconductor, display, and solar industries. has also pioneered sophisticated bioscience systems that are used for the monitoring of life-threatening diseases. 
image

Read More

Conducive policies can make India a global chemical manufacturing hub

Though India offers huge market for chemicals, the government will have to walk the talk to achieve the goals of its ambitious 'Make in India' ...

http://mybs.in/2Rufp8f


Copy tiny URL to save and share articles.

Recommended for you

RECOMMENDED FOR YOU

Advertisements

Back to Top